Structure Therapeutics, Inc. (GPCR)
35.00
-0.10
(-0.28%)
USD |
NASDAQ |
Sep 18, 16:00
35.11
+0.11
(+0.31%)
After-Hours: 20:00
Structure Therapeutics Market Cap : 2.493B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.493B |
| September 17, 2026 | 2.500B |
| September 16, 2026 | 2.528B |
| September 15, 2026 | 2.774B |
| September 14, 2026 | 2.738B |
| September 11, 2026 | 2.753B |
| September 10, 2026 | 2.817B |
| September 09, 2026 | 2.936B |
| September 08, 2026 | 2.876B |
| September 04, 2026 | 3.371B |
| September 03, 2026 | 3.371B |
| September 02, 2026 | 3.404B |
| September 01, 2026 | 3.357B |
| August 31, 2026 | 3.270B |
| August 28, 2026 | 3.374B |
| August 27, 2026 | 3.505B |
| August 26, 2026 | 3.515B |
| August 25, 2026 | 3.555B |
| August 24, 2026 | 3.490B |
| August 21, 2026 | 3.496B |
| August 20, 2026 | 3.598B |
| August 19, 2026 | 3.855B |
| August 18, 2026 | 3.812B |
| August 17, 2026 | 3.829B |
| August 14, 2026 | 3.882B |
| Date | Value |
|---|---|
| August 13, 2026 | 3.896B |
| August 12, 2026 | 3.839B |
| August 11, 2026 | 3.713B |
| August 10, 2026 | 3.832B |
| August 07, 2026 | 3.785B |
| August 06, 2026 | 3.748B |
| August 05, 2026 | 3.599B |
| August 04, 2026 | 3.528B |
| August 03, 2026 | 3.437B |
| July 31, 2026 | 3.414B |
| July 30, 2026 | 3.516B |
| July 29, 2026 | 3.365B |
| July 28, 2026 | 3.404B |
| July 27, 2026 | 3.460B |
| July 24, 2026 | 3.491B |
| July 23, 2026 | 3.610B |
| July 22, 2026 | 3.583B |
| July 21, 2026 | 3.507B |
| July 20, 2026 | 3.339B |
| July 17, 2026 | 3.445B |
| July 16, 2026 | 3.271B |
| July 15, 2026 | 3.526B |
| July 14, 2026 | 3.595B |
| July 13, 2026 | 3.670B |
| July 10, 2026 | 3.792B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.085T |
| Novo Nordisk A/S | 144.68B |
| Pfizer Inc. | 157.63B |
| Johnson & Johnson | 650.20B |
| Merck & Co., Inc. | 362.57B |
Market Cap Related Metrics
| Price to Book Value | 1.840 |
| Price | 35.00 |
| Earnings Yield | -8.80% |